Sartorius AG (SOAGY)
57.43
+0.21
(+0.37%)
USD |
OTCM |
Aug 25, 16:00
Sartorius EPS Diluted (Quarterly) : 0.2219 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2219 |
| March 31, 2026 | 0.1904 |
| December 31, 2025 | 0.1018 |
| September 30, 2025 | 0.1483 |
| June 30, 2025 | 0.1067 |
| March 31, 2025 | 0.1479 |
| December 31, 2024 | 0.0275 |
| September 30, 2024 | 0.0452 |
| June 30, 2024 | 0.0745 |
| March 31, 2024 | 0.1164 |
| December 31, 2023 | 0.0079 |
| September 30, 2023 | 0.0474 |
| June 30, 2023 | 0.3022 |
| March 31, 2023 | 0.292 |
| December 31, 2022 | 0.4544 |
| September 30, 2022 | 0.4458 |
| June 30, 2022 | 0.5158 |
| March 31, 2022 | 0.6743 |
| December 31, 2021 | 0.0785 |
| September 30, 2021 | 0.3667 |
| June 30, 2021 | 0.3912 |
| March 31, 2021 | 0.318 |
| December 31, 2020 | 0.2234 |
| September 30, 2020 | 0.2324 |
| June 30, 2020 | 0.1137 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1479 |
| December 31, 2019 | 0.1148 |
| September 30, 2019 | 0.1268 |
| June 30, 2019 | 0.1462 |
| March 31, 2019 | 0.1255 |
| December 31, 2018 | 0.1667 |
| September 30, 2018 | 0.116 |
| June 30, 2018 | 0.1069 |
| March 31, 2018 | 0.0956 |
| December 31, 2017 | 0.1595 |
| September 30, 2017 | 0.0781 |
| June 30, 2017 | 0.0827 |
| March 31, 2017 | 0.0835 |
| December 31, 2016 | 0.0711 |
| September 30, 2016 | 0.0805 |
| June 30, 2016 | 0.0876 |
| March 31, 2016 | 0.0783 |
| December 31, 2015 | 0.0635 |
| September 30, 2015 | 0.0969 |
| June 30, 2015 | 0.0777 |
| March 31, 2015 | 0.0476 |
| December 31, 2014 | 0.0387 |
| September 30, 2014 | 0.0575 |
| June 30, 2014 | 0.0474 |
| March 31, 2014 | 0.0445 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Mesa Laboratories, Inc. | 0.4916 |
| Austar Lifesciences Ltd. | -- |
| SCHOTT Pharma AG & Co. KGaA | 0.0749 |
| Agilent Technologies, Inc. | 1.198 |
| Bio-Rad Laboratories, Inc. | 13.85 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 107.78M |
| Revenue (Quarterly) | 1.060B |
| Total Expenses (Quarterly) | 983.54M |
| Enterprise Value | 15.64B |
| Gross Profit Margin (Quarterly) | 47.50% |
| Profit Margin (Quarterly) | 10.17% |
| Earnings Yield | 1.15% |
| Operating Earnings Yield | 3.72% |
| Normalized Earnings Yield | 1.388 |